We are live on ! Find out more
MGNX icon

MacroGenics

112 hedge funds and large institutions have $58.5M invested in MacroGenics in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more call options, than puts

Call options by funds: $83K | Put options by funds: $50K

8.72% less ownership

Funds ownership: 85.32%76.6% (-8.7%)

13% less funds holding

Funds holding: 128112 (-16)

14% less capital invested

Capital invested by funds: $68.3M → $58.5M (-$9.82M)

26% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 35

38% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 42

Holders
112
Holders Change
-16
Holders Change %
-12.5%
% of All Funds
1.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
26
Reduced
35
Closed
42
Calls
$83K
Puts
$50K
Net Calls
+$33K
Net Calls Change
+$149K
Name Holding Trade Value Shares
Change
Change in
Stake
PNC Financial Services Group
151
PNC Financial Services Group
Pennsylvania
-$15 -12 Closed
Royal Bank of Canada
152
Royal Bank of Canada
Ontario, Canada
-$6 -4 -5%
C
153
Covestor
United Kingdom
+$55 +38 +211%

MGNX Hedge Fund Activity: Q2 2025 in Review

112 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2025, worth a combined $58.5M — down 14% from $68.3M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of MGNX and 26 opened new positions — a net loss of 16 holders — while 35 trimmed existing stakes and 26 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $2.32M. The largest seller was BlackRock, cutting an estimated $4.49M.

  • 112 institutional investors held MacroGenics (MGNX) as of Q2 2025, down from 128 in Q1 2025.
  • Funds reported $58.5M of MacroGenics stock for Q2 2025, down 14% quarter-over-quarter.
  • 26 funds opened new MacroGenics positions in Q2 2025 and 42 closed out, a net change of -16 holders.
  • The largest MacroGenics buyer in Q2 2025 was EcoR1 Capital, an estimated $2.32M added.
  • The largest MacroGenics seller in Q2 2025 was BlackRock, an estimated $4.49M sold.

Based on aggregated 13F filings for Q2 2025.